A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
India in the Changing Landscape of Life-Sciences Research & Development
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Subscribe To Our Newsletter & Stay Updated
